LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 8 of 497
Next
>>
>
176 to 200 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Imatinib	0.04	uM	LJP6	2	N18	72	hr	1097	3624	3769	0.9614	0.9455
BT-20	Imatinib	0.04	uM	LJP6	3	N18	72	hr	1097	3858	3769	1.0235	1.0331
BT-20	JNK-9L	0.04	uM	LJP6	1	K24	72	hr	1097	3125	3769	0.8290	0.7588
BT-20	JNK-9L	0.04	uM	LJP6	2	K24	72	hr	1097	2724	3769	0.7226	0.6088
BT-20	JNK-9L	0.04	uM	LJP6	3	K24	72	hr	1097	3114	3769	0.8261	0.7547
BT-20	JW-7-24-1	0.04	uM	LJP6	1	B24	72	hr	1097	3130	3769	0.8303	0.7607
BT-20	JW-7-24-1	0.04	uM	LJP6	2	B24	72	hr	1097	2847	3769	0.7553	0.6548
BT-20	JW-7-24-1	0.04	uM	LJP6	3	B24	72	hr	1097	2914	3769	0.7730	0.6799
BT-20	Lapatinib	0.04	uM	LJP6	1	M24	72	hr	1097	3228	3769	0.8563	0.7974
BT-20	Lapatinib	0.04	uM	LJP6	2	M24	72	hr	1097	2936	3769	0.7789	0.6881
BT-20	Lapatinib	0.04	uM	LJP6	3	M24	72	hr	1097	2584	3769	0.6855	0.5564
BT-20	LDN-193189	0.04	uM	LJP5	1	G06	72	hr	1097	3580	3769	0.9497	0.9291
BT-20	LDN-193189	0.04	uM	LJP5	2	G06	72	hr	1097	4047	3769	1.0736	1.1038
BT-20	LDN-193189	0.04	uM	LJP5	3	G06	72	hr	1097	3794	3769	1.0065	1.0092
BT-20	Linifanib	0.04	uM	LJP6	1	J12	72	hr	1097	4076	3769	1.0813	1.1147
BT-20	Linifanib	0.04	uM	LJP6	2	J12	72	hr	1097	3969	3769	1.0529	1.0746
BT-20	Linifanib	0.04	uM	LJP6	3	J12	72	hr	1097	3807	3769	1.0099	1.0140
BT-20	Linsitinib	0.04	uM	LJP5	1	O24	72	hr	1097	3134	3769	0.8314	0.7622
BT-20	Linsitinib	0.04	uM	LJP5	2	O24	72	hr	1097	3674	3769	0.9747	0.9643
BT-20	Linsitinib	0.04	uM	LJP5	3	O24	72	hr	1097	3501	3769	0.9288	0.8995
BT-20	Mitoxantrone	0.04	uM	LJP5	1	C24	72	hr	1097	1374	3769	0.3645	0.1036
BT-20	Mitoxantrone	0.04	uM	LJP5	2	C24	72	hr	1097	1438	3769	0.3815	0.1275
BT-20	Mitoxantrone	0.04	uM	LJP5	3	C24	72	hr	1097	1567	3769	0.4157	0.1758
BT-20	Mitoxantrone	0.04	uM	LJP6	1	C24	72	hr	1097	1587	3769	0.4210	0.1833
BT-20	Mitoxantrone	0.04	uM	LJP6	2	C24	72	hr	1097	1243	3769	0.3298	0.0545

|<
<<
Previous
Page 8 of 497
Next
>>
>
176 to 200 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)